LFMDNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as LFMDP
LifeMD, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$2.25−0.09 (-3.85%)
Close on Oct 19, 2026
- Market cap
- $107.52M
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$3.83 (−62.99%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Earnings
LifeMD, Inc. grew revenue 3.8% to $164.70M over the twelve months to Jun 30, 2026. Free cash flow was -$11.06M, down 161.6% from a year earlier.
Revenue
$164.70M
+3.8% vs. a year earlier
Operating income
-$24.25M
TTM Q2 2026
Free cash flow
-$11.06M
-161.6% vs. a year earlier
EPS, diluted
-$0.05
TTM Q2 2026
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $107.52M
- P/E ratio
- –
- Price to sales
- 0.65
- Price to book
- 13.50
- Dividend yield
- –
- Free cash flow yield
- -10.28%
Fundamentals
- Revenue
- $164.70M
- Net income
- $201.01K
- EPS, diluted
- -$0.05
- Free cash flow
- -$11.06M
- Book value per share
- $0.17
- Diluted shares
- 48M
Fifteen years at a glance
Fiscal years 2011 to 2025 and trailing twelve months, USD
Revenue
$164.70M+3.8% YoY
Gross profit
$141.85M+7.6% YoY
Operating income
-$24.25M
Net income
$201.01K
EPS, diluted
-$0.05
Free cash flow
-$11.06M-161.6% YoY
Reported periodTrailing twelve months